Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution recalled over manufacturing violations
- Recall date
- May 21, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Torrent Pharma Inc recalls Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution, 5 mg/1.5 mg per 5 mL, Rx Only, 16 FL. oz. (473 mL)…
- Recall number
- D-1384-2019
- FDA classification
- Class II
- Brand / firm
- Torrent Pharma Inc
- Sold / distributed
- Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.
Why it was recalled
cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Hydrocodone Bitartrate and Homatropine Methylbromide Oral Solution, 5 mg/1.5 mg per 5 mL, Rx Only, 16 FL. oz. (473 mL) bottle, NDC:13668-577-10 Distributed by Torrent Pharma Inc., Basking Ridge, NJ 07920.
Get recall alerts
Free email alert whenever Torrent Pharma Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Torrent Pharma Inc